ALSINA-FERNANDEZ, Jorge,BOKVIST, Bengt Krister,COSKUN, Tamer,CUMMINS, Robert Chadwick
申请号：
HUE16703620
公开号：
HUE045860T2
申请日:
2016.01.05
申请国别(地区):
HU
年份:
2020
代理人:
摘要：
The present invention relates to dual incretin peptide mimetic compounds that agonize receptors for both human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), and may be useful for treating type 2 diabetes mellitus (T2D).
